Warning letter / Centaur / July 2023 / C
Centaur India formulation facility at Pune, Maharashtra, India was issued Warning letter by FDA citing
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Centaur India formulation facility at Pune, Maharashtra, India was issued Warning letter by FDA citing
Natco Pharma’s sterile products manufacturing facility at Rangareddy, Telengana (FEI 3004540906) was inspected by USFDA
Traditional Chinese Medicine (TCM) encompasses a range of holistic treatments developed over thousands of years. Key
Herbal medicines have been used for thousands of years across different cultures to treat illnesses
Lifestyle refers to the way individuals live their daily lives, encompassing their habits, routines, and
USFDA Inspected UCB Farchim site at Bulle, Switzerland (FEI 3005023799) in June / July 2023.
USFDA 483 / UCB Farchim SA/ June 2023 / Gaps in Data Integrity program, lack